Back to search

Article

A proof-of-concept study: Investigating the impact of<i>COMT</i>genotype and proline on negative symptoms in Alzheimer’s Disease

2025-05-15

Abstract excerpt

<h4>Summary</h4> Previous studies have reported that levels of fasting plasma proline and catechol-O-methyltransferase ( COMT ) Val 158 Met genotype influence negative symptoms in patients with severe psychiatric illness and those at-risk for psychosis. Parallel negative neuropsychiatric symptoms are also a core feature of Alzheimer’s disease (AD). In this proof-of-concept cross-sectional study of dementia patient...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
833360ee-8cb2-5225-9e78-c57131b16b50
DOI
10.1101/2025.05.15.25327175
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A proof-of-concept study: Investigating the impact of<i>COMT</i>genotype and proline on negative symptoms in Alzheimer’s DiseaseDOI 10.1101/2025.05.15.25327175
Select a neighboring publication to make it the new centre.